Philipp Manegold
Impact in
- Oncology top 10%
- Chemokine receptors and signaling
- Colorectal Cancer Treatments and Studies
- Cytokine Signaling Pathways and Interactions
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 13
- Colorectal Cancer Treatments and Studies 9
- HER2/EGFR in Cancer Research 2
-
- Cancer-related gene regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- Georg Lurje (11 shared papers)Alexandra Pohl (6 shared papers)Yan Ning (5 shared papers)Robert D. Ladner (3 shared papers)Melissa J. LaBonte (3 shared papers)Wu Zhang (4 shared papers)Dongyun Yang (4 shared papers)Peter M. Wilson (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)International Journal of Cancer (2 papers)Pharmacogenetics and Genomics (1 paper)Clinical Cancer Research (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Philipp Manegold
23 papers receiving 914 citations
Peers
Comparison fields: 5 of 82
- Oncology 363
- Cancer Research 116
- Immunology 122
- Molecular Biology 352
- Pathology and Forensic Medicine 84
Countries citing papers authored by Philipp Manegold
This map shows the geographic impact of Philipp Manegold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Manegold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Manegold more than expected).
Fields of papers citing papers by Philipp Manegold
This network shows the impact of papers produced by Philipp Manegold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Manegold. The network helps show where Philipp Manegold may publish in the future.
Co-authors
The 25 scholars most cited alongside Philipp Manegold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 356 | |
| 2 | 2008 | 93 | |
| 3 | 2011 | 78 | |
| 4 | 2003 | 51 | |
| 5 | 2009 | 48 | |
| 6 | 2009 | 47 | |
| 7 | 2018 | 45 | |
| 8 | 2009 | 39 | |
| 9 | 2009 | 35 | |
| 10 | 2019 | 31 | |
| 11 | 2019 | 25 | |
| 12 | 2016 | 23 | |
| 13 | 2008 | 16 | |
| 14 | Targeting metastatic colorectal cancer in 2008: a long way from 5-FU. | 2008 | 15 |
| 15 | 2020 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2021 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2008 | 1 | |
| 20 | 2008 | 1 |
About Philipp Manegold
Philipp Manegold is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Hepatology, having authored 23 papers that have together received 927 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Anorectal Disease Treatments and Outcomes (3 papers), Cancer-related gene regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Pelvic floor disorders treatments (2 papers), HER2/EGFR in Cancer Research (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Oncology (363 citations), Cancer Research (116 citations), Immunology (122 citations), Molecular Biology (352 citations) and Pathology and Forensic Medicine (84 citations). Philipp Manegold has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Georg Lurje, Alexandra Pohl, Yan Ning, Robert D. Ladner, Melissa J. LaBonte, Wu Zhang, Dongyun Yang, Peter M. Wilson, Heinz‐Josef Lenz and Young Kwon Hong. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Cancer, Pharmacogenetics and Genomics, Clinical Cancer Research and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.